AGA announced this week that the association’s new venture capital fund, GI Opportunity Fund 1, completed its first investment, rounding out the Series A financing of Virgo Surgical Video Solutions (“Virgo”) of Carlsbad, California.
Virgo provides gastroenterologists, clinical trial sponsors and trial site investigators with AI-fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with IBD clinical trials.
“As its partner in the GI Opportunity Fund, Varia shares AGA’s passion of supporting exciting innovations that benefit the GI field. Our partnership is designed, however, to do more than that. We firmly believe that this fund can also create an unusual opportunity for members interested in venture capital investing at an unusually low entry point. We believe we can accomplish these multiple objectives by making investments in companies like Virgo Surgical Video Solutions. Its video capture, management, and artificial intelligence analysis technology platform holds great promise for advancing the field of endoscopic medicine.”
“While AGA has long guided innovators who share our goal of improving digestive health care, we have doubled down on this commitment by establishing the GI Innovation Fund. The fund’s first investment — Virgo — exemplifies our pursuit of improved clinical care.
Through our venture fund, gastroenterologists can join AGA to invest in fast-growing, early-stage companies that are transforming care for patients with digestive disease.”
“Virgo would not be where it is today without the support of AGA, dating back to our initial pitch at the AGA Tech Summit’s Shark Tank competition in 2018.
Virgo is proud to have the support of AGA, and this investment will help accelerate Virgo’s mission to improve patient outcomes and clinical workflows by developing automation and AI tools for endoscopy.”
Previous
Next
